Biomedical Components Testing Using an XY-Stage
Biomedical device companies are constantly making products that need to be tested during both the development and production phases. Recently, a catheter delivery system was introduced to the market that required a push test of the individual components. This proved to be particularly challenging due to the close proximity between the components and their small size.
Our XY Test Stage was used to position the catheter and an upper probe acted as the force applicator. Using the translational functionality of the stage, we were able to precisely move different areas of the catheter system into the test position without having to detach it from the stage.
The XY Test Stage mounts to our single or dual-column testing systems, as well as most non-Instron universal testing systems. Other common applications of the XY Test Stage include the testing of multiple leads located in biomedical sub-assemblies.
Records management compliance with FDA 21 CFR § 11 is non-negotiable for many Medical Device and Pharmaceutical companies. ComplianceBuilder™ (CB) is a stand-alone, add-on compliance solution that can be integrated with Instron’s Software®Bluehill, providing features necessary to meet the latest FDA 21 CFR § 11 regulations.
Instron 3300 Series Universal Testing Systems for Tensile, Compression, Bend, and other material property tests.
- 2.2 MB
The XY Test Stage is useful for testing components, sub-assemblies, or end products that have multiple elements or leads that need to be tested independently of one another; commonly found in the medical device industry. Mounts to most universal testing instruments.
- 147.3 KB
5900 Universal Testing Systems are engineered for precision, built for durability, and offer the flexibility for changing requirements. They are designed with standard and optional features that increase testing efficiency and improve the testing experience for the operator. A wide range of models are available for testing capacities from < 100N up to 600kN.
- 6.8 MB
For Medical Device and Pharmaceutical companies, records management compliance with FDA 21 CFR § 11 is non-negotiable. ComplianceBuilder™ (CB) is a stand-alone, add-on compliance solution that can be integrated with Instron’s Bluehill® Software to provide features necessary to meet the latest FDA 21 CFR § 11 regulations.
- 0.5 MB